Full Year 2025 Target Healthcare REIT PLC Earnings Call Transcript
Key Points
- Target Healthcare REIT PLC (LSE:THRL) has consistently outperformed the MSCI Annual Healthcare Property Index, achieving a 77% outperformance over 11 years.
- The company boasts a robust defensive portfolio with modern, fit-for-purpose care homes, contributing to a 9.3% total accounting return for the year.
- The portfolio's average rent cover is at its highest since IPO, at over 1.9x, indicating strong financial health and stability.
- Target Healthcare REIT PLC (LSE:THRL) successfully executed its largest disposal since IPO, selling assets at an 11.6% premium to book value, demonstrating strong demand for its properties.
- The company has a strong acquisition pipeline with over GBP150 million of accretive investment opportunities, ensuring future growth and portfolio enhancement.
- The company faced challenges with tenant administration, resulting in increased operating expenses and credit loss allowances.
- EPRA earnings per share decreased by 0.8% due to exceptional costs incurred during the year.
- The debt refinancing led to an increase in the weighted average cost of drawn debt from 3.9% to 4.3%, reflecting the expiry of previous hedging arrangements.
- One tenant was unable to meet rental obligations, leading to administration and additional costs for the company.
- The company operates in a regulated sector with potential legislative challenges, such as those related to upward-only rent reviews, which could impact future operations.
Good morning. Thank you for coming to the annual results presentation for Target Healthcare REIT. My name is Kenneth MacKenzie, and I'm delighted to be joined this morning by my colleague, Alastair Murray, who was appointed CFO for the Fund Management business a couple of months ago. Alastair has actually been with us for 2.5 years. He's the guy who was Director of Listed Funds.
He did this work, and now he's having the joy of presenting the work that he's done over the last 2.5 years. And we're also joined by James Mackenzie. James joined us at the beginning of the year. So it's a bit of a fresh team, though we continue to do what we've always done. James was General Counsel at Aegon for a dozen years, and we're delighted to have him with us.
What we're going to do in the presentation is, I will do some highlights, what's going on within the sector and within Target Healthcare REIT in particular. And then Alastair will take us through the financial performance. James, through the portfolio performance. And I'll close it
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
